CVS Health Corp
Change company Symbol lookup
Select an option...
CVS CVS Health Corp
NVAX Novavax Inc
MRK Merck & Co Inc
HYT BlackRock Corporate High Yield Fund, Inc
FNMA Federal National Mortgage Association
CPKF Chesapeake Financial Shares Inc
AGNC Agnc Investment Corp
BYND Beyond Meat Inc
NDENF Central African Gold Inc
HD Home Depot Inc
Go

Health Care : Health Care Providers & Services | Large Cap Value
Company profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Closing Price
$58.78
Day's Change
-0.81 (-1.36%)
Bid
--
Ask
--
B/A Size
--
Day's High
60.44
Day's Low
58.71
Volume
(Above Average)
Volume:
6,983,876

10-day average volume:
6,113,377
6,983,876

Micron's stock swings to a gain after profit, revenue outlook raised

2:06 pm ET May 27, 2020 (MarketWatch)
Print

Shares of Micron Technology Inc. (MU) spiked up 3.7% in afternoon trading Wednesday, after the memory chip maker raised its profit and revenue outlook for the fiscal third-quarter. The company disclosed that it now expects adjusted earnings per share of 75 cents to 80 cents, above the FactSet consensus of 56 cents, and revenue of $5.2 billion to $5.4 billion, which is above expectations of $4.93 billion. When the company reported fiscal second-quarter results on March 25 (http://www.marketwatch.com/story/micron-shares-rise-6-on-revenue-that-beats-wall-street-estimates-2020-03-25), the company said it expected adjusted EPS of 55 cents, plus or minus 15 cents, and revenue of $4.6 billion to $5.2 billion. Just before the raised outlook, the stock was trading down 2.6%. It has now lost 6.0% over the past three months, while the PHLX Semiconductor Index has climbed 9.3% and the S&P 500 has advanced 1.1%.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

May 27, 2020 14:06 ET (18:06 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.